Haemonetics Corp
XMUN:HAZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Haemonetics Corp
XMUN:HAZ
|
US |
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
JP |
|
Genenta Science SPA
F:K5F
|
IT |
Multiples-Based Value
The Multiples-Based Value for
Haemonetics Corp (HAZ) under the Base Case is 80.51 EUR.
Compared with the current market price of 92 EUR, the stock appears
Overvalued by 12% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.